Daunocyte 20 mg Injection
$2.88
$2.25
Daunocyte 20 mg Injection is a potent immunosuppressant designed for the effective treatment of acute leukemia, particularly in pediatric patients suffering from acute lymphocytic leukemia (ALL) and acute myeloid leukemia (AML). This formulation contains daunorubicin, which functions by targeting and obliterating the abnormal white blood cells that characterize these malignancies. By disrupting the growth of these cancerous cells, Daunocyte plays a crucial role in managing the disease and improving patient outcomes. It is essential to monitor patients for potential side effects, including heart complications and infections, as immunosuppression may increase susceptibility to various health risks. Always consult a healthcare professional before starting treatment to ensure it aligns with individual health needs and conditions. With careful administration and oversight, Daunocyte 20 mg Injection can significantly contribute to the fight against leukemia, enhancing the quality of life for those affected. Remember to follow prescribed dosages and report any adverse reactions to your doctor promptly for optimal safety and effectiveness.
मात्रा
Active Pharmaceutical Ingredient
Uses
• Daunocyte 20 mg injection is primarily used in the treatment of acute leukemia. This type of cancer affects the blood and bone marrow, leading to the rapid proliferation of abnormal white blood cells. By administering Daunocyte 20 mg injection, healthcare providers aim to reduce the number of these abnormal cells, helping to restore normal blood cell production. This treatment is crucial for managing the disease effectively.
• In cases of acute lymphocytic leukemia (ALL), Daunocyte 20 mg injection plays a vital role in the therapeutic regimen. This specific cancer primarily affects lymphoid cells, which are essential components of the immune system. The injection works by targeting and destroying the rapidly dividing cancerous cells, thus aiding in the recovery of healthy cell function. Patients receiving Daunocyte 20 mg injection may experience improved outcomes in their treatment journey.
• Acute myeloid leukemia (AML) is another condition for which Daunocyte 20 mg injection is indicated. This aggressive form of leukemia requires prompt intervention to halt disease progression. By using Daunocyte 20 mg injection, oncologists can effectively target the malignant myeloid cells, which helps in controlling the disease. The timely administration of this injection can be critical in improving patient prognosis.
• Daunocyte 20 mg injection is often utilized in combination with other therapies to enhance its effectiveness in treating acute leukemia. This multidrug approach can help address various aspects of the disease, maximizing the chances of remission. The synergistic effects of Daunocyte 20 mg injection with other chemotherapeutic agents can lead to better patient responses. Oncologists frequently rely on this treatment as part of a comprehensive care plan for leukemia patients.
Benefits
Acute leukemia: Acute leukemia is a type of cancer that starts in the bone marrow, the soft, spongy tissue found inside bones where blood cells are produced. It is characterized by the rapid growth of abnormal white blood cells, which are responsible for fighting infections. Daunocyte 20 mg Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Acute lymphocytic blood cancer: Acute Lymphoblastic Leukemia (ALL), also known as acute lymphocytic leukemia, is a type of cancer that affects the bone marrow and blood. It is characterized by the rapid and uncontrolled growth of immature white blood cells called lymphoblasts or lymphocytes. Daunocyte 20 mg Vial kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Acute myeloid blood cancer: Acute Myeloid Leukemia (AML), also known as acute myelogenous leukemia, is a type of cancer that affects the bone marrow and blood. It is characterized by the rapid and uncontrolled growth of abnormal myeloid cells, which are responsible for producing red blood cells, white blood cells, and platelets. Daunocyte 20 mg Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells.
Side Effects
Like all medicines, this Daunocyte Injection can cause side effects, although not everybody gets them. If you are worried about side effects, you should discuss them with your doctor.
Most Common Side Effects
• Pain
• Hair loss
• Mouth sores
• Throat pain
• Hematuria ( Red discolouration of urine
• blood in urine)
• Weight gain
• Tiredness
• Pale skin
• Cold extremities (hands and feet)
• Chills
• Diarrhoea
• Nausea
• Vomiting
• Fever
Common Side Effects
• Shortness of breath
• Irregular Heartbeats ( Cardiac Arrhythmias)
• Low blood counts
• AKI (Acute kidney injury)
• It may include symptoms like no adequate amount of urine or no urine, pedal oedema ( swelling in feet or ankles)
• Liver Injury
• Pain in the stomach, loss of appetite, jaundice ( yellowish of the skin and eyes), clay-coloured stool
How To Use
Your physician or nurse will give you this medicine. Kindly do not self-administer.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Daunocyte 20 mg Vial. It may increase the risk of liver damage. It is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: patients with kidney disease should closely monitor kidney function while taking Daunocyte 20 mg Injection and report any unusual symptoms or changes in kidney function to their physician. The dose of Daunocyte 20 mg should be used with caution in patients with kidney disease. It is important to adjust the dose in patients with kidney disease.
• Breastfeeding: It is not recommended to breastfeed while taking Daunocyte Injection. Daunocyte 20 mg Injection may pass into breast milk and harm the infant. If you are breastfeeding and taking Daunocyte 20 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Daunocyte 20 mg Injection should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Daunocyte 20 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Daunocyte Injection may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Daunocyte Injection may be unsafe during pregnancy, as animal studies indicate that it may harm the developing fetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Daunocyte 20 mg Injection during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Daunorubicin Injection 20 mg may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions, such as avoiding driving a vehicle or operating heavy machinery, if you suffer from the side effects of this Anti-cancer Drug Daunocyte.